• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The prevalence of primary ovarian insufficiency in Sweden; a national register study.瑞典原发性卵巢功能不全的患病率;一项全国性登记研究。
BMC Womens Health. 2018 Oct 25;18(1):175. doi: 10.1186/s12905-018-0665-2.
2
Association of genetic disorders and congenital malformations with premature ovarian insufficiency: a nationwide register-based study.遗传疾病和先天畸形与卵巢早衰的关联:一项全国范围内基于注册的研究。
Hum Reprod. 2023 Jun 1;38(6):1224-1230. doi: 10.1093/humrep/dead066.
3
Being born preterm or with low weight implies a risk of infertility and premature loss of ovarian function; a national register study.出生早产或体重过低意味着不孕和卵巢功能早衰的风险;一项全国登记研究。
Ups J Med Sci. 2020 Aug;125(3):235-239. doi: 10.1080/03009734.2020.1770380. Epub 2020 Jun 12.
4
Premature ovarian insufficiency in female adolescent and young adult survivors of non-gynecological cancers: a population-based cohort study.非妇科癌症女性青少年和年轻成年幸存者的卵巢早衰:基于人群的队列研究。
Reprod Health. 2023 Jan 2;20(1):4. doi: 10.1186/s12978-022-01559-8.
5
Autoimmune polyglandular syndrome type 3 (APS-3) among patients with premature ovarian insufficiency (POI).卵巢早衰(POI)患者中的自身免疫性多腺体综合征3型(APS-3)。
Eur J Obstet Gynecol Reprod Biol. 2016 Aug;203:61-5. doi: 10.1016/j.ejogrb.2016.05.023. Epub 2016 May 20.
6
Primary Ovarian Insufficiency in Women With Addison's Disease.女性艾迪生病患者的原发性卵巢功能不全。
J Clin Endocrinol Metab. 2021 Jun 16;106(7):e2656-e2663. doi: 10.1210/clinem/dgab140.
7
Incidence and prevalence of primary ovarian insufficiency in South Korea: a population-based study.韩国原发性卵巢功能不全的发病率和患病率:一项基于人群的研究。
Arch Gynecol Obstet. 2021 Sep;304(3):823-831. doi: 10.1007/s00404-021-05962-7. Epub 2021 Jan 25.
8
No mutations in the PSMC3IP gene identified in a Swedish cohort of women with primary ovarian insufficiency.在瑞典一组原发性卵巢功能不全女性中未发现PSMC3IP基因的突变。
Sex Dev. 2014;8(4):146-50. doi: 10.1159/000357605. Epub 2014 Jan 29.
9
Previous cancers in women diagnosed with premature ovarian insufficiency: A nationwide population-based case-control study.曾患癌症的女性被诊断为卵巢早衰:一项全国范围内基于人群的病例对照研究。
Acta Obstet Gynecol Scand. 2024 May;103(5):842-849. doi: 10.1111/aogs.14783. Epub 2024 Jan 27.
10
Prevalence of Stress Urinary Incontinence in Women with Premature Ovarian Insufficiency.患有卵巢早衰的女性压力性尿失禁的患病率。
J Womens Health (Larchmt). 2018 Dec;27(12):1508-1512. doi: 10.1089/jwh.2018.6935. Epub 2018 Nov 28.

引用本文的文献

1
Sexual health outcomes after colorectal cancer diagnosis in females: a population-based cohort study.女性结直肠癌诊断后的性健康结局:一项基于人群的队列研究。
J Natl Cancer Inst. 2025 Sep 1;117(9):1817-1824. doi: 10.1093/jnci/djaf120.
2
Genetics Investigation of Idiopathic Premature Ovarian Insufficiency: Contribution of Array-CGH and Next-Generation Sequencing.特发性卵巢早衰的遗传学研究:比较基因组杂交芯片和新一代测序技术的作用
Genes (Basel). 2025 Feb 22;16(3):251. doi: 10.3390/genes16030251.
3
Development and evaluation of a Register-Based Organ Damage Index in systemic lupus erythematosus: a nationwide, population-based study from Sweden.基于登记系统的系统性红斑狼疮器官损伤指数的开发与评估:一项来自瑞典的全国性、基于人群的研究。
Lupus Sci Med. 2025 Feb 26;12(1):e001403. doi: 10.1136/lupus-2024-001403.
4
Mechanisms of He Shi Yu Lin formula in treating premature ovarian insufficiency: insights from network pharmacology and animal experiments.和时毓麟方治疗卵巢早衰的机制:基于网络药理学和动物实验的见解
J Ovarian Res. 2024 Dec 27;17(1):254. doi: 10.1186/s13048-024-01575-1.
5
Primary ovarian insufficiency consequence of autoimmune diseases: a bidirectional two-sample Mendelian randomization study.自身免疫性疾病导致的原发性卵巢功能不全:一项双向两样本孟德尔随机化研究
Front Endocrinol (Lausanne). 2024 Dec 9;15:1417896. doi: 10.3389/fendo.2024.1417896. eCollection 2024.
6
Primary ovarian insufficiency: update on clinical and genetic findings.原发性卵巢功能不全:临床与遗传学研究进展。
Front Endocrinol (Lausanne). 2024 Sep 26;15:1464803. doi: 10.3389/fendo.2024.1464803. eCollection 2024.
7
Premature ovarian insufficiency.卵巢早衰。
Nat Rev Dis Primers. 2024 Sep 12;10(1):63. doi: 10.1038/s41572-024-00547-5.
8
Anti-Müllerian hormone and fertility in women after childhood cancer treatment: Association with current infertility risk classifications.抗苗勒管激素与儿童癌症治疗后女性的生育能力:与当前不孕风险分类的关联。
PLoS One. 2024 Aug 12;19(8):e0308827. doi: 10.1371/journal.pone.0308827. eCollection 2024.
9
Effects of chemical activation versus fragmentation on human ovarian tissue and follicle growth in culture.化学激活与分割对培养的人卵巢组织和卵泡生长的影响。
Hum Reprod Open. 2024 May 22;2024(3):hoae028. doi: 10.1093/hropen/hoae028. eCollection 2024.
10
Significance of oxidative stress and antioxidant capacity tests as biomarkers of premature ovarian insufficiency: A case control study.氧化应激和抗氧化能力测试作为早发性卵巢功能不全生物标志物的意义:一项病例对照研究。
World J Clin Cases. 2024 Jan 26;12(3):479-487. doi: 10.12998/wjcc.v12.i3.479.

本文引用的文献

1
Early menarche, nulliparity and the risk for premature and early natural menopause.初潮早、未生育与过早及自然绝经早期的风险
Hum Reprod. 2017 Mar 1;32(3):679-686. doi: 10.1093/humrep/dew350.
2
The prevalence and phenotypic characteristics of spontaneous premature ovarian failure: a general population registry-based study.自发性卵巢早衰的流行率和表型特征:一项基于人群登记的研究。
Hum Reprod. 2015 May;30(5):1229-38. doi: 10.1093/humrep/dev021. Epub 2015 Feb 23.
3
Hormone therapy might be underutilized in women with early menopause.激素治疗在早绝经女性中可能未被充分利用。
Hum Reprod. 2015 Apr;30(4):848-52. doi: 10.1093/humrep/dev017. Epub 2015 Feb 5.
4
Sex hormone replacement in ovarian failure - new treatment concepts.卵巢功能衰竭的性激素替代治疗-新理念。
Best Pract Res Clin Endocrinol Metab. 2015 Jan;29(1):105-14. doi: 10.1016/j.beem.2014.09.010. Epub 2014 Oct 2.
5
Validation of oesophageal cancer surgery data in the Swedish Patient Registry.验证瑞典患者登记处的食管癌手术数据。
Acta Oncol. 2012 Jan;51(1):65-8. doi: 10.3109/0284186X.2011.633932.
6
External review and validation of the Swedish national inpatient register.瑞典全国住院患者登记处的外部审查和验证。
BMC Public Health. 2011 Jun 9;11:450. doi: 10.1186/1471-2458-11-450.
7
Clinical practice. Primary ovarian insufficiency.临床实践。原发性卵巢功能不全。
N Engl J Med. 2009 Feb 5;360(6):606-14. doi: 10.1056/NEJMcp0808697.
8
Primary ovarian insufficiency: a more accurate term for premature ovarian failure.原发性卵巢功能不全:卵巢早衰的一个更准确术语。
Clin Endocrinol (Oxf). 2008 Apr;68(4):499-509. doi: 10.1111/j.1365-2265.2007.03073.x. Epub 2007 Oct 29.
9
Incidence of premature ovarian failure.卵巢早衰的发病率。
Obstet Gynecol. 1986 Apr;67(4):604-6.

瑞典原发性卵巢功能不全的患病率;一项全国性登记研究。

The prevalence of primary ovarian insufficiency in Sweden; a national register study.

作者信息

Lagergren Katarina, Hammar Mats, Nedstrand Elizabeth, Bladh Marie, Sydsjö Gunilla

机构信息

Division of Obstetrics and Gynecology, Department of Clinical and Experimental Medicine, Faculty of Medicine and Health Sciences, Linköping University, SE-58185, Linköping, Sweden.

出版信息

BMC Womens Health. 2018 Oct 25;18(1):175. doi: 10.1186/s12905-018-0665-2.

DOI:10.1186/s12905-018-0665-2
PMID:30359245
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6202813/
Abstract

BACKGROUND

The current estimates of the prevalence of primary ovarian insufficiency (POI) are very variable, but are in most studies believed to be around 1%. It is also very likely tat the prevalence of POI differs between countries and over time. We therefore aimed to assess the prevalence of primary ovarian insufficiency in Sweden.

METHODS

All 1,036,918 women born between 1973 and 1993 in Sweden were included. The prevalence of POI was based on data from the Swedish Patient Register through the diagnosis code or through the Prescribed Drug Register. The number of women below 40 years of age diagnosed with the ICD-10 diagnoses E28.3 or E89.4, and women who had been dispensed drugs for treatment of climacteric symptoms were included.

RESULTS

Out of the 1,036,918 women, 19,253 (1.9%) had POI. The prevalence of spontaneous POI was 1.7% and the prevalence of iatrogenic POI was 0.2%. Most women (98.8%) with POI were identified from the Prescribed Drug Register; only 4.1% were found in the Patient Register, whereas 2.9% were identified in both registers.

CONCLUSIONS

The total prevalence of POI was 1.9%, 95% CI: 1.7-2.1, indicating a higher prevalence than often previously reported.

摘要

背景

目前对原发性卵巢功能不全(POI)患病率的估计差异很大,但在大多数研究中认为约为1%。POI的患病率在不同国家和不同时期也很可能有所不同。因此,我们旨在评估瑞典原发性卵巢功能不全的患病率。

方法

纳入了所有1973年至1993年在瑞典出生的1,036,918名女性。POI的患病率基于瑞典患者登记册通过诊断代码或处方药物登记册的数据。纳入了年龄在40岁以下被诊断为ICD-10编码E28.3或E89.4的女性,以及已配药用于治疗更年期症状的女性。

结果

在1,036,918名女性中,19,253名(1.9%)患有POI。自发性POI的患病率为1.7%,医源性POI的患病率为0.2%。大多数患有POI的女性(98.8%)是从处方药物登记册中识别出来的;只有4.1%是在患者登记册中发现的,而2.9%在两个登记册中都被识别出来。

结论

POI的总患病率为1.9%,95%置信区间:1.7 - 2.1,表明患病率高于先前经常报道的水平。